IP Library Patent Application 18722064
Patent Application
App. No. 18/722,064

EMITTING MATERIALS FOR ELECTROLUMINESCENT DEVICES AND OTHER APPLICATIONS

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
18/722,064
Abstract

The present disclosure generally relates to emitting organic molecules, including but not limited to, thiazoles such as 1,3-thiazoles, 4-methyl-1,3-thiazoles, etc. In some cases, the molecules are able to emit in blue or green wavelengths. In some aspects, such molecules may be used in organic light emitting diodes. In certain embodiments, the molecules may comprise one or more bridge moieties and one or more chromophores in certain cases. In some embodiments, these molecules can be used as electroluminescent media in devices requiring light emission as a function of applied voltage. Other embodiments of the disclosure are generally directed to systems and devices using such molecules, methods of using such molecules, e.g., to control the emission of light, kits involving such molecules, or the like.

Claims (36)

1 . A method, comprising:

applying voltage to an electroluminescent material comprising a 1,3-thiazole to cause the electroluminescent material to exhibit light emission, wherein the 1,3-thiazole comprises a structure:

wherein each of R 1 , R 2 , and R 3 is independently an aromatic group or —H such that only one of R 2 and R 3 is —H.

2 . The method of claim 1 , wherein the 1,3-thiazole comprises a structure:

wherein R 1 is a coumarin, R 3 is a fluorene, and R 2 is —H.

3 . The method of claim 2 , wherein the coumarin has a structure:

wherein R 4 , R 5 , R 6 , R 7 , and R 8 are independently selected from the group consisting of —H, an alkyl, a cycloalkyl, an aromatic, a heterocyclic, an imidazolyl, a pyridyl, a pyrazinyl, a pyrimidinyl, a piperidinyl, a pyrazolyl, a hydroxyl, an alkoxy, an amine, an alkylamine, a dialkylamine, an arylamine, an amide, an N-substituted amide, an alkyl sulfonyl, a ketone, a sulfonamide, a nitrile, a nitro, a halogen, a trifluoromethyl, a trichloromethyl, a tribromomethyl, or an acyl.

4 . The method of claim 3 , wherein R 5 is diethylamine, and R 4 , R 6 , R 7 , and R 8 are each —H.

5 . The method of claim 2 , wherein the fluorene has a structure:

wherein R 9 , R 10 , R 11 , R 12 , R 13 , R 14 , R 15 , and R 16 are independently selected from the group consisting of —H, an alkyl, a cycloalkyl, an aromatic, a heterocyclic, an imidazolyl, a pyridyl, a pyrazinyl, a pyrimidinyl, a piperidinyl, a pyrazolyl, a hydroxyl, an alkoxy, an amine, an alkylamine, a dialkylamine, an arylamine, an amide, an N-substituted amide, an alkyl sulfonyl, a ketone, a sulfonamide, a nitrile, a nitro, a halogen, a trifluoromethyl, a trichloromethyl, a tribromomethyl, or an acyl.

6 . The method of claim 5 , wherein R 9 , R 10 , R 11 , R 12 , R 13 , R 14 , R 15 , and R 16 are each —H.

7 . The method of claim 2 , wherein the 1,3-thiazole comprises a structure:

8 . (canceled)

9 . The method of claim 1 , wherein the 1,3-thiazole comprises a structure:

wherein R 1 is a furan, R 2 is an oxadiazole, and R 3 is methyl.

10 . The method of claim 9 , wherein the oxadiazole has a structure:

wherein R 17 , R 18 , R 19 , R 20 , R 21 , R 22 , and R 23 are independently selected from the group consisting of —H, an alkyl, a cycloalkyl, an aromatic, a heterocyclic, an imidazolyl, a pyridyl, a pyrazinyl, a pyrimidinyl, a piperidinyl, a pyrazolyl, a hydroxyl, an alkoxy, an amine, an alkylamine, a dialkylamine, an arylamine, an amide, an N-substituted amide, an alkyl sulfonyl, a ketone, a sulfonamide, a nitrile, a nitro, a halogen, a trifluoromethyl, a trichloromethyl, a tribromomethyl, or an acyl.

11 . The method of claim 10 , wherein R 17 , R 18 , R 19 , R 20 , R 21 , R 22 , and R 23 are each —H.

12 . The method of claim 9 , wherein the oxadiazole is 2-(naphthalen-1-yl)-1,3,4-oxadiazole.

13 . The method of claim 9 , wherein the furan has a structure:

wherein R 24 , R 25 , R 26 , R 27 , and R 28 are independently selected from the group consisting of —H, an alkyl, a cycloalkyl, an aromatic, a heterocyclic, an imidazolyl, a pyridyl, a pyrazinyl, a pyrimidinyl, a piperidinyl, a pyrazolyl, a hydroxyl, an alkoxy, an amine, an alkylamine, a dialkylamine, an arylamine, an amide, an N-substituted amide, an alkyl sulfonyl, a ketone, a sulfonamide, a nitrile, a nitro, a halogen, a trifluoromethyl, a trichloromethyl, a tribromomethyl, or an acyl.

14 . The method of claim 13 , wherein R 24 , R 25 , R 26 , R 27 , and R 28 are each —H.

15 . (canceled)

16 . The method of any one of claim 9 , wherein the 1,3-thiazole comprises a structure:

17 . The method of claim 1 , wherein the 1,3-thiazole is selected from FIGS. 10 - 23 .

18 . The method of claim 1 , wherein the 1,3-thiazole is selected from the group consisting of the following molecules, each identified by a first hash block of an InChIKey representation of the molecule: AAIFIJHQPULVMI, ZEXBHUPLNIGHEZ, QOLRRWCRWYQMLR, GXVWHVFJXJITDO, XBWCSDLHQPFVRP, FTOBIPSLLFQWGQ, XUDAQKXVVYVOMW, SWXMNBXTODAPJU, IMUZIXSBGCDBDO, LFUMMFVQFZGISH, LFUMMFVQFZGISH, OWGMSZXTMKECCI, FVKPJEPVXUOALV, DQIFIRZAHLHCSV, UYUUIVYOLSYCML, XGQROYXDUMHMKQ, GDGVBBPMHUAWER, SWUVVXLGXKQWOK, DKGOKAARXPCDJB, AQSPXOQHZFBFDI, BXZOOIPJUSPRDW, FSDQOJYTVJRTHL, YUEYOBZWLODUGC, GBQCXTMGESMUEL, OGKZAJYSJBFSOG, QTGAIVYNKJBHEJ, GAOSHNRBJWVZDA, HNWAWCPRDIBDDE, WOFQROVFBXYBOZ, HHVBGAXPRFMPGS, CTBHRVFXOWLCLT, SNPNGHYHZNWCPM, IFCNOEBWGRXPBH, CZFNZPVICSEKKV, BQGVNJWCBFSZQK, ZRNUAICMPZORBH, APFNLFNUHQLJDG, JHTGJOZYPSMACV, LNACLYIJOUNWRW, LNPNEMBJXUSTRM, UNHOUQALCJXAAY, QDOVKCKZAFNXEC, GXVIHPNZPLMOFI, LTMQBXYXRIZMLG, CGRRZMMRRFNWPW, PTEIMXYLBHMYET, OXGRFYSZCWOZFS, DSWWUPRZCBKXLE, OYAZGLJGAVEGBZ, IMTDFCZBMXEELU, WOTFSSPRRQWLBU, VWEXHTKBKCUGLB, HKALLZZMGBMRGJ, DEVSOZBTEMFORY, DHMAFZYIVUIGJM, IBFRLZWMQUPRPR, CTCKQLXMUVOIOU, RFFDKFSLLAFKMM, FEKZKTRIFUBKER, DVQPXNLTBBDOIZ, JUOGGWLHDVNOBX, IBYTUCBHKIXOIW, ZWDQNGQLKSREND, VISGKGWXPGXKBL, UARGLLSVBPBWMS, QCBIHGXCUPKGRY, RPOBMJZIHYTRAU, HFYABEGBJVTUML, FFALRSFIGCORHO, ULRNJTPMFKQCMO, HZYZTHMJYSLSMJ, JUBQNCLMFCHMQN, DJRPCUJSQLWPAZ, SRJYATBZLBEBJY, XPGJQECYTKNGRN, NJWNZBKTAPHFTH, BEMNWKLFFWUKDU, SILYRWRXVMHRTM, YDYHMDFVQIVLML, ZOMAJIOFMSVVNT, ISYKKWICBXSHKY, LOPXOGLVYSLSGC, SPZYRPPRLBUQAH, VYJVFVAIWLSCED, ZDCQXVUZVLQKLY, JHQCZXRSVLVYOW, KMGAKZISGVDXGW, BGYXIGIIRVQASS, YNAZTCWGRIOKCB, FFLDFNQQENULNK, PBIPJNJUZRAYHE, KIPVEMHJQKNZFL, LDYKAHFEBNQUGJ, VJTJFGNPPUSEQE, IELYXTSOHBZECP, ISCMOHOLBLISMQ, RRYUMHOBKQOGAD, PFQCMMXHKKNLOT, VIMFKWUTJUEQJK, POBQTDRNVWERPF, CFSSKPPFJCBYMY, FWVIVAJNBPEESS, JROPTVRWUXYQMR, FCLLWHJYNSGBMQ, PHXINTIMPBVAIX, JBJUKSOOTJPZHH, ICYVZGRFKOFTAD, PWMMHOOXMFCACY, UGVPJXSWPBOMJP, QLXCDVXTOMYAMU, QIBGZDFTXWBTMI, RLDSMSDTKCVPRO, KMHRNTKTYZADTN, BMSBKLICNZLUBE, HXTPVMBISBGNAC, JHLRLFFIUWGHDV, VLBHFTWJPSDFIE, NCXAIOZZQAVZMI, SVKUUBRDEQXQLR, BJUWJXPRDCKMNI, IZRFGTAUUUKGTM, DAJDHRGFWQVASM, BHXHUNWNDBGQMO, XKCKUCWGKCCQGV, KWHAUGPQNZAJDS, NEZXCGPTAYIZCU, GICLYTUDYTXFRS, PRHUAJBGRRUGHJ, PASWKTPBVDOBBE, GIXSXCOUMMISFJ, YUCWUNZRDPXDNR, HBZINHRGTVCNDG, NBTNJXPNOBISRV, VPRSWFQXIXZSBI, ICYBHLYOCZWBFD, ABPFDSNHUAFYPV, RALCBWCBMXROBW, VGFMNTFZYOFFLG, YWQMKNAAENETQK, HYQHOTXHFKNJHU, ZXVYYXLJDXCZCI, MXWPXHCLXWQNNW, SHJHMYRRZLUUKL, JYSSHXMOBVYXSS, RAQWJQONIVFTFW, GSXZETKDCIEKIE, PASWKTPBVDOBBE, GIXSXCOUMMISFJ, YUCWUNZRDPXDNR, HBZINHRGTVCNDG, NBTNJXPNOBISRV, VPRSWFQXIXZSBI, ICYBHLYOCZWBFD, ABPFDSNHUAFYPV, RALCBWCBMXROBW, VGFMNTFZYOFFLG, YWQMKNAAENETQK, HYQHOTXHFKNJHU, ZXVYYXLJDXCZCI, MXWPXHCLXWQNNW, SHJHMYRRZLUUKL, JYSSHXMOBVYXSS, RAQWJQONIVFTFW, GSXZETKDCIEKIE, MHLSVUZSMRYLIZ, ZQBXLMSVNMMTCS, KEEVEQZIGAQZKE, WOMDNAPZTGCNJL, ADNZGPRKIJKESU, QXEMFQGQZKRSTJ, SOAPJSITMYDWDL, GKCJZXSGGINQDD, NIDRNHQAGJOWFJ, VJMBREBKNLAOIZ, TVUGXXXCGDLQBU, AECIIKUVLSLILY, TZIAQFUWVSWNHI, and CUDMJKXXXZXZGS.

19 . The method of claim 1 , wherein the electroluminescent material exhibits light emission.

20 . (canceled)

21 . The method of claim 1 , wherein the electroluminescent material exhibits light emission at a wavelength of between 300 nm and 400 nm.

22 . The method of claim 1 , wherein the electroluminescent material exhibits light emission at a wavelength of between 450 nm and 600 nm.

23 - 24 . (canceled)

25 . The method of claim 1 , wherein the electroluminescent material is contained within an electroluminescent device.

26 . The method of claim 25 , wherein the electroluminescent device is a display.

27 - 28 . (canceled)

29 . The method of claim 25 , wherein the electroluminescent device is an automotive luminaire.

30 - 67 . (canceled)

Assignments (2)
RELEASE OF SECURITY INTEREST Recorded Oct 2, 2024
From: FIRST-CITIZENS BANK & TRUST COMPANY
To: KEBOTIX, INC.
Reel/Frame 068768/0622 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 25, 2024
From: SAYKIN, SEMION; CAMPBELL, VICTORIA; DUHOVIC, SELMA; WHEELER, DAVID LEE; RYAN, KEVIN; ELDO, SREELETHA JOBY; RICKE, NATHAN DARRELL PETERSON; HU, ZHONGWEI; SHEBERLA, DENNIS; MCDAVID, JHAYLEN
To: KEBOTIX, INC.
Reel/Frame 067821/0942 →